Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

Completed · Phase 2

Conditions studied: Sarcoma

In brief

Phase II trial to study the effectiveness of topotecan in treating children who have recurrent, relapsed, or refractory sarcoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Key facts

Study ID
NCT00003745
Run by
National Cancer Institute (NCI)
People needed
125
Starts
1999-05-01
Last updated by the study team
2013-02-05

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.